364 related articles for article (PubMed ID: 9358554)
1. Stabilization of 10-hydroxycamptothecin in poly(lactide-co-glycolide) microsphere delivery vehicles.
Shenderova A; Burke TG; Schwendeman SP
Pharm Res; 1997 Oct; 14(10):1406-14. PubMed ID: 9358554
[TBL] [Abstract][Full Text] [Related]
2. The acidic microclimate in poly(lactide-co-glycolide) microspheres stabilizes camptothecins.
Shenderova A; Burke TG; Schwendeman SP
Pharm Res; 1999 Feb; 16(2):241-8. PubMed ID: 10100309
[TBL] [Abstract][Full Text] [Related]
3. Poly(D,L-lactic-co-glycolic acid) microspheres for sustained delivery and stabilization of camptothecin.
Ertl B; Platzer P; Wirth M; Gabor F
J Control Release; 1999 Sep; 61(3):305-17. PubMed ID: 10477803
[TBL] [Abstract][Full Text] [Related]
4. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.
Blanco D; Alonso MJ
Eur J Pharm Biopharm; 1998 May; 45(3):285-94. PubMed ID: 9653633
[TBL] [Abstract][Full Text] [Related]
5. Stabilization of vinca alkaloids encapsulated in poly(lactide-co-glycolide) microspheres.
Marinina J; Shenderova A; Mallery SR; Schwendeman SP
Pharm Res; 2000 Jun; 17(6):677-83. PubMed ID: 10955840
[TBL] [Abstract][Full Text] [Related]
6. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
Witschi C; Doelker E
J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
[TBL] [Abstract][Full Text] [Related]
7. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA.
Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
J Control Release; 1999 Aug; 60(2-3):279-86. PubMed ID: 10425333
[TBL] [Abstract][Full Text] [Related]
8. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
Kwon YM; Kim SW
Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics.
Bittner B; Morlock M; Koll H; Winter G; Kissel T
Eur J Pharm Biopharm; 1998 May; 45(3):295-305. PubMed ID: 9653634
[TBL] [Abstract][Full Text] [Related]
10. Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF.
Pettit DK; Lawter JR; Huang WJ; Pankey SC; Nightlinger NS; Lynch DH; Schuh JA; Morrissey PJ; Gombotz WR
Pharm Res; 1997 Oct; 14(10):1422-30. PubMed ID: 9358556
[TBL] [Abstract][Full Text] [Related]
11. Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles, and sterilization process.
Herrero-Vanrell R; Ramirez L; Fernandez-Carballido A; Refojo MF
Pharm Res; 2000 Oct; 17(10):1323-8. PubMed ID: 11145241
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the initial burst release of a model peptide from poly(D,L-lactide-co-glycolide) microspheres.
Wang J; Wang BM; Schwendeman SP
J Control Release; 2002 Aug; 82(2-3):289-307. PubMed ID: 12175744
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery.
Woo BH; Jiang G; Jo YW; DeLuca PP
Pharm Res; 2001 Nov; 18(11):1600-6. PubMed ID: 11758769
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly(D,L-lactide-co-glycolide) microspheres.
Wang J; Wang BM; Schwendeman SP
Biomaterials; 2004 May; 25(10):1919-27. PubMed ID: 14738856
[TBL] [Abstract][Full Text] [Related]
16. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.
Su Z; Sun F; Shi Y; Jiang C; Meng Q; Teng L; Li Y
Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1251-6. PubMed ID: 19881277
[TBL] [Abstract][Full Text] [Related]
17. Sustained release microspheres of metoclopramide using poly(D,L-lactide-co-glycolide) copolymers.
Elkheshen SA; Radwan MA
J Microencapsul; 2000; 17(4):425-35. PubMed ID: 10898083
[TBL] [Abstract][Full Text] [Related]
18. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
Duvvuri S; Janoria KG; Pal D; Mitra AK
J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
[TBL] [Abstract][Full Text] [Related]
19. Porcine insulin biodegradable polyester microspheres: stability and in vitro release characteristics.
Shao PG; Bailey LC
Pharm Dev Technol; 2000; 5(1):1-9. PubMed ID: 10669912
[TBL] [Abstract][Full Text] [Related]
20. Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres.
Rosa GD; Iommelli R; La Rotonda MI; Miro A; Quaglia F
J Control Release; 2000 Nov; 69(2):283-95. PubMed ID: 11064135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]